Drugs & Therapy Perspectives

, Volume 5, Issue 4, pp 10–12 | Cite as

Tips for increasing antidepressant prescribing precision

New Drugs and Therapeutics


Venlafaxine Trazodone Postpartum Depression Moclobemide Mianserin 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Brown WA, Khan A. Which depressed patients should receive antidepressants? CNS Drugs 1994; 1: 341–7CrossRefGoogle Scholar
  2. 2.
    Joyce PR, Paykel ES. Predictors of drug response in depression. Arch Gen Psychiatry 1989; 46: 89–99PubMedCrossRefGoogle Scholar
  3. 3.
    American Psychiatric Association. Practice guidelines for major depressive disorder in adults. Am J Psychiatry 1993 Apr; 150 Suppl.: 1–26Google Scholar
  4. 4.
    Montgomery SA, Bebbington P, Cowen P, et al. Guidelines for treating depressive illness with antidepressants. A statement from the British Association for Psychopharmacology. J Psychopharmacol 1993; 7: 19–23PubMedGoogle Scholar
  5. 5.
    Kind P, Sorensen J. The costs of depression. Int Clin Psychopharmacol 1993; 7: 191–5PubMedCrossRefGoogle Scholar
  6. 6.
    Jonsson B, Bebbington PE. What price depression? The cost of depression and the cost-effectiveness of pharmacological treatment. Br J Psychiatry 1994; 164: 665–73PubMedCrossRefGoogle Scholar
  7. 7.
    Reversible MAO-A inhibitors offer better tolerability than older antidepressants. Drug Ther Perspect 1994 Sep 19; 4: 12–14Google Scholar
  8. 8.
    Freemantle N, House A, Song F, et al. Prescribing of selective serotonin reuptake inhibitors as a strategy for prevention of suicide. BMJ 1994; 309: 249–53PubMedCrossRefGoogle Scholar
  9. 9.
    Stewart A. Antidepressant pharmacotherapy: cost comparison of SSRIs and TCAs. Br J Med Econ 1994; 7: 67–79Google Scholar
  10. 10.
    Glassman AH, Stage KB. Depressed patients with cardiovascular disease. Treatment considerations. CNS Drugs 1994; 1: 435–40CrossRefGoogle Scholar
  11. 11.
    Cantú TG, Korek JS, Romanoski AJ. Focus on venlafaxine. A new option for the treatment of depression. Hosp Form 1994; 29: 25–33Google Scholar

Copyright information

© Adis International Limited 1995

Personalised recommendations